EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma

Farrukh T Awan iD, Ran Liu, Hsin-Hui Huang iD, Matthew Bye, Kwang Woo Ahn iD, Gabriel Krigsfeld, Anat Raz, Heather Wolfe iD, Mehdi Hamadani iD

British Journal of Haematology · 2026-11 · 209 (5) · 2284-2288

DOI: 10.1111/bjh.70803 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 31.08.2026. Verfasst von Farrukh T Awan und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Hematopoietic Stem Cell Transplantation, Pyrimidines, Pyrazoles. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellHematopoietic Stem Cell TransplantationPyrimidinesPyrazolesHumansPiperidinesAdenineChromosome DeletionFemaleChromosomes, Human, Pair 17Middle AgedMaleTransplantation, HomologousRetrospective StudiesAgedRecurrenceSmith-Magenis Syndrome

Stichwörter der Autor:innen

allogeneic haematopoietic stem cell transplantationchronic lymphocytic leukaemiadel(17p)

Substanzen

ibrutinibPiperidinesAdeninePyrimidinesPyrazoles

Autor:innen und Institutionen

  • University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • AbbVie, North Chicago, Illinois, USA.
  • Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

ORCID-Profile: Farrukh T Awan, Hsin-Hui Huang, Kwang Woo Ahn, Heather Wolfe, Mehdi Hamadani

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • AbbVie

Zitieren

APA

Awan, F. T., Liu, R., Huang, H. H., Bye, M., Ahn, K. W., Krigsfeld, G., Raz, A., Wolfe, H., & Hamadani, M. (2026). Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology, 209(5), 2284-2288. https://doi.org/10.1111/bjh.70803

Vancouver

Awan FT, Liu R, Huang HH, Bye M, Ahn KW, Krigsfeld G, et al. Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology. 2026;209(5):2284-2288. doi:10.1111/bjh.70803

BibTeX
@article{Awan2026,
  author = {Awan, Farrukh T and Liu, Ran and Huang, Hsin-Hui and Bye, Matthew and Ahn, Kwang Woo and Krigsfeld, Gabriel and Raz, Anat and Wolfe, Heather and Hamadani, Mehdi},
  title = {Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {5},
  pages = {2284--2288},
  doi = {10.1111/bjh.70803}
}
Kostenlos starten →